Spineway Financials
| ALSPW Stock | EUR 0.15 0.01 6.25% |
Spineway |
Understanding current and past Spineway Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Spineway's financial statements are interrelated, with each one affecting the others. For example, an increase in Spineway's assets may result in an increase in income on the income statement.
Spineway Stock Summary
Spineway competes with Spineguard, DBT SA, and Biophytis. Spineway SA engages in the design, manufacture, and marketing of implants and surgical instruments for treating disorder of spinal column. Spineway SA was incorporated in 2005 and is headquartered in Ecully, France. SPINEWAY operates under Medical Instruments Supplies classification in France and is traded on Paris Stock Exchange. It employs 34 people.| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0011398874 |
| Business Address | 7 allee Moulin |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.spineway.com |
| Phone | 33 4 72 77 01 52 |
| Currency | EUR - Euro |
You should never invest in Spineway without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Spineway Stock, because this is throwing your money away. Analyzing the key information contained in Spineway's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Spineway Key Financial Ratios
Spineway's financial ratios allow both analysts and investors to convert raw data from Spineway's financial statements into concise, actionable information that can be used to evaluate the performance of Spineway over time and compare it to other companies across industries.| Return On Equity | -0.0836 | |||
| Return On Asset | -0.041 | |||
| Target Price | 2.9 | |||
| Number Of Employees | 10 | |||
| Beta | 1.45 |
Spineway Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Spineway's current stock value. Our valuation model uses many indicators to compare Spineway value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Spineway competition to find correlations between indicators driving Spineway's intrinsic value. More Info.Spineway is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Spineway's earnings, one of the primary drivers of an investment's value.Spineway Systematic Risk
Spineway's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Spineway volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Spineway correlated with the market. If Beta is less than 0 Spineway generally moves in the opposite direction as compared to the market. If Spineway Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Spineway is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Spineway is generally in the same direction as the market. If Beta > 1 Spineway moves generally in the same direction as, but more than the movement of the benchmark.
Spineway March 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Spineway help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Spineway. We use our internally-developed statistical techniques to arrive at the intrinsic value of Spineway based on widely used predictive technical indicators. In general, we focus on analyzing Spineway Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Spineway's daily price indicators and compare them against related drivers.
| Downside Deviation | 7.05 | |||
| Information Ratio | 0.122 | |||
| Maximum Drawdown | 54.96 | |||
| Value At Risk | (9.09) | |||
| Potential Upside | 29.17 |
Additional Tools for Spineway Stock Analysis
When running Spineway's price analysis, check to measure Spineway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spineway is operating at the current time. Most of Spineway's value examination focuses on studying past and present price action to predict the probability of Spineway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spineway's price. Additionally, you may evaluate how the addition of Spineway to your portfolios can decrease your overall portfolio volatility.